Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Review

Comparative Study

Clinical Trial

Multicenter Study

Research Support, N.I.H., Extramural

Clinical Trial, Phase III

Meta-Analysis

Systematic Review

Controlled Clinical Trial

Observational Study

Network Meta-Analysis

Publication Year

From

Quick links

Individual year

2022

2021

2020

2018

2017

2016

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Nebivolol""[mesh_terms]

40 Results

Searching titles within these results

Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study.

Athanasios J Manolis, Jinho Shin, Yu Jeong Choi, Geu-Ru Hong, Dong Woon Jeon, Dae-Hyeok Kim, Young Youp Koh, Giuseppe Mancia, Hyuck-Jun Yoon, Sang Won Park

Journal of hypertension 2021;38(3):527-535

Full Text

Abstract

One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk.

Jan N Basile

The American journal of medicine 2010;123(7 Suppl 1):S9-15

Full Text

Abstract

Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension.

U Martin, F Dunne, A Sharma, P Peter

Journal of clinical pharmacy and therapeutics 2006;31(2):153-9

Full Text

Abstract

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling.

Gil Arbel, Lior Gepstein, Luigi Venetucci, William G Newman, Susan J Kimber, Irit Huber, Benjamin Brown, Nicola Bates, Amira Gepstein, Leonid Maizels, Claire Hopton, Anke J Tijsen

Physiological reports 2022;10(8):e15265

Free Full Text

Abstract

Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation.

Robert Weiss

Vascular health and risk management 2007;2(3):303-8

Free Full Text

Abstract

Beta-blockers in the management of hypertension: focus on nebivolol.

Vasilios Papademetriou, David Wojciechowski

Expert review of cardiovascular therapy 2008;6(4):471-9

Full Text

Abstract

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia.

Moo-Yong Rhee, Cheol Ho Kim, Youngkeun Ahn, Joon-Han Shin, Seung Hwan Han, Hyun-Jae Kang, Soon Jun Hong, Hae-Young Kim

Drug design, development and therapy 2021;14():5005-5017

Free Full Text

Abstract

The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.

Evangelos Rizos, Eleni Bairaktari, Angeliki Kostoula, George Hasiotis, Apostolos Achimastos, Emanuel Ganotakis, Moses Elisaf, D P Mikhailidis

Journal of cardiovascular pharmacology and therapeutics 2003;8(2):127-34

Full Text

Abstract

Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.

Luc M Van Bortel, Francesco Fici, Flavio Mascagni

American journal of cardiovascular drugs : drugs, devices, and other interventions 2008;8(1):35-44

Full Text

Abstract

Arterial stiffness, hypertension, and rational use of nebivolol.

Damiano Rizzoni, Enzo Porteri, Enrico Agabiti-Rosei

Vascular health and risk management 2009;5(1):353-60

Free Full Text

Abstract

Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive Hispanic postmenopausal women.

Barry J Materson, Alberto B Alonso, Richard A Preston, David Afshartous, Rolando Rodco

Hypertension (Dallas, Tex. : 1979) 2014;64(2):287-95

Full Text

Abstract

Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.

Michel P Hermans, Olivier De Coster, Laurence Seidel, Adelin Albert, Philippe Van de Borne

Blood pressure. Supplement 2010;1():5-14

Full Text

Abstract

Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation.

Anna Fratta Pasini, Ulisse Garbin, Maria Cristina Nava, Chiara Stranieri, Anna Davoli, Tatsuya Sawamura, Vincenzo Lo Cascio, Luciano Cominacini

Journal of hypertension 2005;23(3):589-96

Full Text

Abstract

Managing endothelial dysfunction in COVID-19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double-blind, placebo-controlled, randomized clinical trial.

Georges Ghanem, Gibran Atwi, Jean-Michel Saad, Ahmad Moussawi, Tarik Abu Saad, Nibal Chamoun, Rami Tabbikha, Pascale Salameh, Soad Al Osta, Wassim Jamaleddine, Abdulrahman Al Kotob, Kamal Matli, Omar Jamal, Jacques Mokhbat

Clinical and translational science 2022;15(10):2323-2330

Free Full Text

Abstract

Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.

Vasilios Papademetriou

The American journal of cardiology 2009;103(2):273-8

Full Text

Abstract

Results: 1 – 15 / 40

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Nebivolol""[mesh_terms]

Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study.

One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk.

Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension.

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling.

Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation.

Beta-blockers in the management of hypertension: focus on nebivolol.

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia.

The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.

Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.

Arterial stiffness, hypertension, and rational use of nebivolol.

Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive Hispanic postmenopausal women.

Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.

Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation.

Managing endothelial dysfunction in COVID-19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double-blind, placebo-controlled, randomized clinical trial.

Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.

Results for
""Nebivolol""[mesh_terms]